Last10K.com

Karyopharm Therapeutics Inc. (KPTI) SEC Filing 8-K Material Event for the period ending Wednesday, October 24, 2018

Karyopharm Therapeutics Inc.

CIK: 1503802 Ticker: KPTI

View differences made from one to another to evaluate Karyopharm Therapeutics Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Karyopharm Therapeutics Inc..

Continue

Assess how Karyopharm Therapeutics Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Karyopharm Therapeutics Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: KPTI
CIK: 1503802
Form Type: 8-K Corporate News
Accession Number: 0001193125-18-308292
Submitted to the SEC: Fri Oct 26 2018 7:10:04 AM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Wednesday, October 24, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/kpti/0001193125-18-308292.htm